CAMP4 Therapeutics (CAMP) Analyst & Key Data

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

17

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.25

Median Target+123.53%

$9.50

Potential upside vs current price

DCF Value-93.25%

$0.29

Potential downside vs current price

Current Stock Price

$4.25

Median Target+123.53%

$9.50

Potential upside vs current price

DCF Value-93.25%

$0.29

Potential downside vs current price

Analyst Consensus

Buy3 analysts

Buy

Updated Sep 12, 2026

Total Analysts3

Buy

17

Hold

6

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

C

DCF Score1.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score1.0 / 5

Price / Earnings Score1.0 / 5

ROA Score1.0 / 5

ROE Score5.0 / 5

Valuation

Current Stock Price

$4.25

Median Target+123.53%

$9.50

Potential upside vs current price

DCF Value-93.25%

$0.29

Potential downside vs current price

Current Stock Price

$4.25

Median Target+123.53%

$9.50

Potential upside vs current price

DCF Value-93.25%

$0.29

Potential downside vs current price

CAMP4 Therapeutics Corporation